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ABSTRACT 
The oral mucosa is conveniently and easily accessible and therefore allows uncomplicated application of dosage forms. A rapid-dissolving drug 
delivery system, in most cases, is a tablet that dissolves or disintegrates in the oral cavity without the need for water or chewing. More recently, 
fast-dissolving films are gaining interest as an alternative to fast-dissolving tablets to definitely eliminate patients’ fear of chocking and 
overcome patent impediments. In the present study, calculations for amount of drugs were determined, Rapid dissolving films containing GSH 
were prepared using solvent casting method. An aqueous solution of polymer was prepared in distilled water. For preparing the  solution, 
polymer was soaked in water for some time (wherever required). This was followed by addition of GSH in the aqueous solution of the polymer. 
Now, plasticizer (PEG 400 and/or Glycerol), sweetening agent (Aspartame and/or Sucralose), citric acid and flavor were also added to this 
solution. In-vitro disintegration time (DT) of the prepared rapid dissolving films was determined visually in a glass beaker containing 50 ml 
water and swirling every 10 seconds. Average of 3 films was taken for this purpose.  In-vivo DT of the prepared rapid dissolving film was 
determined by mouth in three human volunteers. Evaluation of taste was done by a taste panel with 2mg drug and subsequently one film held 
in the mouth for 10-15 seconds. For preparing rapid dissolving films, varying amount of Pullulan, METHO K3P, METHO E3P were taken. Solvent 
evaporation method was used for preparation of the film. Various polymers used in the study were: Pullulan, Metho K3P, Metho E3P, Metho 
E15P and Poly N10. PEG-400 and glycerol were used as plasticizer. Aspartame and sucralose were used as sweetening agent while citric acid 
was used as saliva stimulating agent 
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1. INTRODUCTION: 
The oral cavity has been investigated as a site for drug 
delivery for a long period of time. In 1847 Sobrero found 
that nitroglycerine was absorbed from the oral cavity. Since 
then various active substances have been investigated for 
local or systemic use. Drug delivery through the oral cavity 
offers many advantages. The oral mucosa is conveniently 
and easily accessible and therefore allows uncomplicated 
application of dosage forms. Furthermore, the oral mucosa is 
robust against local stress or damage and shows fast cellular 
recovery after such incidents. Active Substances can be 
administered locally to treat oral diseases like periodontal 
disease, bacterial and fungal infections or aphthous 
stomatitis. A systemic action can be achieved via drug 
permeation through the mucosal endothelium. For systemic 
drug absorption, various dosage forms and devices, e.g. 
buccal patches, buccoadhesive discs and mechatronic 
delivery devices have recently been developed. The use of 
buccal patches allows drug absorption to be terminated 
immediately upon simple removal of the patch. The 
aforementioned advantages of drug administration via the 
oral cavity offer new possibilities in the administration of 
drugs to “problematical” subpopulations like children and 
the elderly. These patients have special drug administration 
requirements as they are often unable to swallow solid 
dosage forms (e.g. tablets, capsules).  
A rapid-dissolving drug delivery system, in most cases, is a 
tablet that dissolves or disintegrates in the oral cavity 
without the need for water or chewing. Most rapid-
dissolving delivery system films must include substances to 
mask the taste of the active ingredient. This masked active 
Khunteta et al                                                                                                    Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):516-527  
ISSN: 2250-1177                                                                                  [517]                                                                                 CODEN (USA): JDDTAO 
ingredient is then swallowed by the patient's saliva along 
with the soluble and insoluble excipients. 
1.1 Research & Development of the Technology: 
One of the primary objectives in developing the rapid 
dissolving drug delivery system was to identify and satisfy 
an unmet need of general and specific populations (pediatric 
and geriatric patients) and to improve compliance and 
dosing ease for the patient. This system is a fast-dissolving 
film that allows children, elderly, and the general population 
to take their medications discretely wherever and whenever 
needed, satisfying an unmet need. Table below summarizes 
the special features and advantages of a film drug delivery 
system. 
Table 1: Special features and advantages of a film drug 
delivery system 
Special features Advantages 
Thin elegant film 
Various sizes and shapes 
Unobstructive 
Mucoadhesion 
Fast disintegration 
Quick dissolving 
Rapid release 
Convenient dosing 
No water needed 
No risk of choking 
Taste masking 
Enhanced stability 
Improved patient compliance 
Life cycle management  
 
Fast Dissolving Tablet (FDT): Recently fast dissolving drug 
delivery systems have started gaining popularity and 
acceptance as new drug delivery system, because they are 
easy to administer and lead to better patient compliance. 
They also impart unique product differentiation thus 
enabling use as line extension for existing commercial 
products. FDTs can be prepared by various techniques like 
direct compression, sublimation, melt granulation, 
moulding, volatilization and freeze drying. 
1.2 Rapid Dissolving Films (RDFs): 
More recently, fast-dissolving films are gaining interest as an 
alternative to fast-dissolving tablets to definitely eliminate 
patients’ fear of chocking and overcome patent 
impediments. Fast-dissolving films are generally constituted 
of plasticized hydrocolloids or blends made of thereof that 
can be laminated by solvent casting or hot-melt extrusion. 
Thin film drug delivery, also referred to as orally dissolving 
thin film, and has emerged as an advanced alternative to the 
traditional tablets, capsules and liquids often associated with 
prescription and OTC medications. Similar in size, shape and 
thickness to a postage stamp, thin film strips are typically 
designed for oral administration, with the person placing the 
strip on or under the tongue or along the inside of the cheek. 
 
 
2. EXPERIMENTAL WORK/ FORMULATION 
STUDIES 
2.1 Calculation for amount of drug 
Diameter of Petri Dish = 9.6 cm,   
So area of petri dish = 72.4 cm2 
Size of film: 3x2 cm2 (= 6 cm2),  
So required amount of GSH in one petri dish will be 
equivalent to 12 film (=72.4 cm2/6 cm2). 
Dose of GSH per strip = 2.24 mg (equivalent to 2 mg 
Granisetron base), 
So amount of GSH taken per petri dish = 2.24x12 = 26.88 mg 
(27 mg)  
Actual/final number of film obtained from each petri dish 
(after cutting into size of 3x2 cm2) = 07 strips/petri dish15 
 
(Fig.- 1: Cutting of rapid dissolving film from each petri dish) 
2.2 Method of Preparation 
Rapid dissolving films containing GSH were prepared using 
solvent casting method. An aqueous solution of polymer was 
prepared in distilled water. For preparing the solution, 
polymer was soaked in water for some time (wherever 
required). This was followed by addition of GSH in the 
aqueous solution of the polymer. Now, plasticizer (PEG 400 
and/or Glycerol), sweetening agent (Aspartame and/or 
Sucralose), citric acid and flavor were also added to this 
solution. This solution was cast on a 9.6 cm diameter petri 
dish, containing a lining of liquid mercury (for leveling 
purpose). It was then dried at room temperature for 24 
hours. The film was carefully removed from the petri dishes, 
checked for imperfections, and cut to the desired size (3x2 
cm2) to deliver the equivalent dose per strip. The strips were 
packed individually into aluminium foil and stored in a 
desiccator for further analysis. 
For preparing rapid dissolving films, varying amount of 
polymer(s) was taken. Amount of plasticizer(s), sweetening 
agent(s), citric acid and flavor(s) were also varied to prepare 
films with desired properties. 
2.3 Determination of In-Vitro Disintegration Time (DT) 
In-vitro disintegration time (DT) of the prepared rapid 
dissolving films was determined visually in a glass beaker 
containing 50ml water and swirling every 10 seconds. 
Average of 3 films was taken for this purpose. 
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(Fig.-2: Disintegration of rapid dissolving film: Initial, during disintegration, complete disintegration) 
2.4 Determination of In-Vivo Disintegration Time 
In-vivo DT of the prepared rapid dissolving film was 
determined by mouth in three human volunteers. A rapid 
dissolving film was placed on the tongue of the volunteers 
and the time required to for disintegration of rapid 
dissolving film in the mouth was recorded. 
2.5 Evaluation of Taste 
Evaluation of taste was done by a taste panel with 2mg drug 
and subsequently one film held in the mouth for 10-15 
seconds. The volunteers were asked to spit out, and the 
bitterness level was recorded. Volunteers were asked to 
gargle with distilled water before and after each taste 
evaluation. The taste of the rapid dissolving film was rated 
on a scale from 1 to 5. Scale 1 was equal to no taste and 5 
was equivalent to too much of the respective taste. 
 1 = no bitter taste  
 2 = very slightly bitter 
3 = slightly bitter 
 4 = moderately bitter 
 5 = bitter (equivalent to pure drug)  
3. FILM FORMER 
3.1 Formulation of rapid dissolving film using Pullulan 
as film former 
For preparing rapid dissolving films, varying amount of 
Pullulan was taken. Amount of plasticizer (PEG 400 and/or 
glycerol), sweetening agent (Aspartame and/or Sucralose), 
citric acid and flavor (Passion fruit or lemon flavor) were 
also varied to prepare films with desired properties. 
3.2 Formulation of rapid dissolving film using Methocel 
K3 Premium Hydroxyl Propyl Methylcellulose (Metho 
K3P) as film former 
For preparing rapid dissolving films, varying amount of 
METHO K3P was taken. Amount of plasticizer (PEG 400 
and/or glycerol), sweetening agent (Aspartame and/or 
Sucralose), citric acid and flavor (Passion fruit or lemon 
flavor) were also varied to prepare films with desired 
properties. 
3.3 Formulation of rapid dissolving film using Methocel 
E3 Premium Hydroxyl Propyl Methylcellulose (Metho 
E3P) as film former 
For preparing rapid dissolving films, varying amount of 
METHO E3P was taken. Amount of plasticizer (PEG 400 
and/or glycerol), sweetening agent (Aspartame and/or 
Sucralose), citric acid and flavor (Passion fruit or lemon 
flavor) were also varied to prepare films with desired 
properties. 
4. RESULT AND DISCUSSION: 
4.1 Formulation of rapid dissolving film using Pullulan 
as film former 
4.1.1Optimization of Amount of Polymer (Pullulan) 
 
 
Table 2: Optimization of Amount of Polymer - Pullulan 
Formulation 
Code 
Amount of 
Pullulan (mg) 
Amount of water 
(ml) 
Result 
TPAP 1 200 20 No film 
TPAP 2 300 20 No film 
TPAP 3 400 20 Very thin film 
TPAP 4 500 20 Film formed 
TPAP 5 600 20 Thick film 
*500 mg of Pullulan was taken for film formation in further studies. 
 
 
 
 
 
Khunteta et al                                                                                                    Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):516-527  
ISSN: 2250-1177                                                                                  [519]                                                                                 CODEN (USA): JDDTAO 
4.1.2 Optimization of Amount of Plasticizer (PEG 400/ Glycerol) for Pullulan 
4.1.2.1 Optimization of amount of PEG 400 alone as plasticizer for Pullulan 
Table 3: Optimization of amount of PEG 400 alone as plasticizer for Pullulan 
Formulation 
Code 
Amount of 
Pullulan (mg) 
Amount of PEG 
400 (mg) 
Amount of 
water (ml) 
Result 
TPAPEG 1 500 25 20 Brittle film 
TPAPEG 2 500 50 20 Brittle film 
TPAPEG 3 500 75 20 Film is not flexible 
TPAPEG 4 500 100 20 Less Flexible film 
TPAPEG 5 500 150 20 Flexible film 
TPAPEG 6 500 200 20 Flexible film 
* 150 mg of PEG400 alone was taken as plasticizer for Pullulan in further studies. 
 
4.1.3 Optimization of amount of Glycerol alone as plasticizer for Pullulan 
Table 4: Optimization of amount of Glycerol alone as plasticizer for Pullulan 
Formulation 
Code 
Amount of 
Pullulan (mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TPAGL 1 500 25 20 Brittle film 
TPAGL 2 500 50 20 Film is not flexible 
TPAGL 3 500 75 20 Less flexible film 
TPAGL 4 500 100 20 Flexible film 
TPAGL 5 500 150 20 Flexible film 
TPAGL6 500 200 20 Flexible but sticky film 
* 100 mg of Glycerol alone was taken as plasticizer for Pullulan in further studies. 
 
4.1.4 Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for Pullulan 
Table 5: Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for Pullulan 
Formulation 
Code 
Amount of 
Pullulan (mg) 
Amount of 
PEG 400 (mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TPAPGL 1 500 25 50 20 Less flexible film 
TPAPGL 2 500 25 75 20 Less flexible film 
TPAPGL 3 500 50 50 20 Less flexible film 
TPAPGL 4 500 50 75 20 Flexible film 
TPAPGL 5 500 75 50 20 Less flexible film 
TPAPGL6 500 75 75 20 Sticky film 
TPAPGL 7 500 100 50 20 Flexible film 
TPAPGL8 500 100 75 20 Sticky film 
* Two combinations (a) 50 mg of PEG400 + 75 mg of Glycerol and (b) 100 mg of PEG400 + 
50mg of Glycerol were taken as plasticizer for Pullulan in further studies. 
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4.1.5 Formulation of Rapid dissolving film using Pullulan as polymer 
Based upon various trial batches, total eight formulations (P01 – P08) were designed for preparation of rapid dissolving film 
using Pullulan as film former.  
Table 6: Formulation of rapid dissolving film using Pullulan as polymer 
                          Formulation 
Ingredients 
P01 P02 P03 P04 P05 P06 P07 P08 
Pullulan (mg) 500 500 500 500 500 500 500 500 
GSH (mg) 27 27 27 27 27 27 27 27 
PEG 400 (mg) 150 150 - - 50 50 100 100 
Glycerol (mg) - - 100 100 75 75 50 50 
Aspartame (mg) 25 - 25 - 15 15 15 15 
Sucralose (mg) - 25 - 25 10 15 10 15 
Citric acid (mg) - - 20 25 25 30 25 25 
Passion fruit (ml) - - 0.1 - - 0.1 0.1 - 
Lemon flavor (ml) - 0.1 - 0.1 0.1 - - 0.1 
Distilled Water (ml) 20 20 20 20 20 20 20 20 
In-vitro DT (sec.) 45 46 40 42 48 45 51 52 
In-vivo DT (sec.) 42 40 35 36 40 39 48 50 
Taste 4 4 2 3 3 2 3 3 
*Based upon parameters like disintegration time, taste etc, two formulations i.e., P03 and P06 were found to be optimum for 
preparation of rapid dissolving film using Pullulan as film former. So, these two films were further studied for various 
parameters. 
4.2 Formulation of rapid dissolving film using Methocel K3 Premium Hydroxyl Propyl Methylcellulose (Metho K3P) as 
film former 
4.2.1 Optimization of Amount of Polymer (METHO K3P) 
Table 7: Optimization of Amount of Polymer - METHO K3P 
Formulation 
Code 
Amount of METHO K3P 
(mg) 
Amount of 
water (ml) 
Result 
TMK3PAP 1 300 20 No film 
TMK3PAP 2 400 20 No film 
TMK3PAP 3 500 20 Very thin film 
TMK3PAP 4 600 20 Film formed 
TMK3PAP 5 700 20 Thick film 
* 600 mg of METHO K3P was taken for film formation in further studies. 
4.2.1.1Optimization of Amount of Plasticizer (PEG 400/ Glycerol) for METHO K3P 
4.2.1.2 Optimization of amount of PEG 400 alone as plasticizer for METHO K3P 
Table 8: Optimization of amount of PEG 400 alone as plasticizer for METHO K3P 
Formulation Code 
Amount of METHO 
K3P (mg) 
Amount of 
PEG 400 (mg) 
Amount of 
water (ml) 
Result 
TMK3PAPEG 1 600 25 20 Brittle film 
TMK3PAPEG 2 600 50 20 Brittle film 
TMK3PAPEG 3 600 75 20 Less flexible film 
TMK3PAPEG 4 600 100 20 Flexible film 
TMK3PAPEG 5 600 150 20 Flexible film 
TMK3PAPEG 6 600 200 20 Flexible film but sticky 
* 100 mg of PEG400 alone was taken as plasticizer for METHO K3P in further studies. 
4.2.2 Optimization of amount of Glycerol alone as plasticizer for METHO K3P 
Table 9: Optimization of amount of Glycerol alone as plasticizer for METHO K3P 
Formulation Code 
Amount of 
METHO K3P (mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TMK3PAGL 1 600 25 20 Brittle film 
TMK3PAGL 2 600 50 20 Film is not flexible 
TMK3PAGL 3 600 75 20 Flexible film 
TMK3PAGL 4 600 100 20 Flexible film 
TMK3PAGL 5 600 150 20 Flexible film 
TMK3PAGL6 600 200 20 Flexible but sticky film 
* 75 mg of Glycerol alone was taken as plasticizer for METHO K3P in further studies. 
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4.2.3 Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO K3P 
Table 10: Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO K3P 
Formulation Code 
Amount of 
METHO K3P (mg) 
Amount of PEG 400 
(mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TMK3PAPGL 1 600 25 25 20 Less flexible film 
TMK3PAPGL 2 600 25 50 20 Less flexible film 
TMK3PAPGL 3 600 50 25 20 Less flexible film 
TMK3PAPGL 4 600 50 50 20 Flexible film 
TMK3PAPGL 5 600 75 25 20 Flexible film 
TMK3PAPGL6 600 75 50 20 Flexible film but sticky 
TMK3PAPGL 7 600 100 25 20 Sticky film 
TMK3PAPGL8 600 100 50 20 Sticky film 
* Two combinations (a) 50 mg of PEG400 + 50 mg of Glycerol and (b) 75 mg of PEG400 + 25mg of Glycerol were taken as 
plasticizer for METHO K3P in further studies. 
4.2.4Formulation of rapid dissolving film using METHO K3P as polymer 
Based upon various trial batches, total eight formulations (MK3P01 – MK3P08) were designed for preparation of rapid 
dissolving film using METHO K3P as film former.  
Table 11: Formulation of rapid dissolving film using METHO K3P as polymer 
                    Formulation 
Ingredients 
MK3P01 MK3P02 MK3P03 MK3P04 MK3P05 MK3P06 MK3P07 MK3P08 
METHO K3P (mg) 600 600 600 600 600 600 600 600 
GSH (mg) 27 27 27 27 27 27 27 27 
PEG 400 (mg) 100 100 - - 50 50 75 75 
Glycerol (mg) - - 75 75 50 50 25 25 
Aspartame (mg) 25 - 25 - 15 15 15 15 
Sucralose (mg) - 25 - 25 10 15 10 15 
Citric acid (mg) - - 20 25 25 30 25 25 
Passion fruit (ml) - - 0.1 - 0.1 - 0.1 - 
Lemon flavor (ml) - 0.1 - 0.1 - 0.1 - 0.1 
Distilled Water (ml) 20 20 20 20 20 20 20 20 
In-vitro DT (sec.) 42 41 35 35 30 28 45 38 
In-vivo DT (sec.) 38 40 28 30 35 34 40 40 
Taste 4 4 3 2 3 2 2 3 
* Based upon parameters like disintegration time, taste etc, two formulations i.e., MK3P04 and MK3P06 were found to be 
optimum for preparation of rapid dissolving film using METHO K3P as film former. So, these two films were further studied for 
various parameters. 
4.3 Formulation of rapid dissolving film using Methocel E3 Premium Hydroxyl Propyl Methylcellulose (METHO E3P) as 
film former 
4.3.1 Optimization of Amount of Polymer (METHO E3P) 
Table 12: Optimization of Amount of Polymer - METHO E3P 
Formulation Code Amount of METHO E3P (mg) Amount of water (ml) Result 
TME3PAP 1 300 20 No film 
TME3PAP 2 400 20 Very thin film 
TME3PAP 3 500 20 Film formed 
TME3PAP 4 600 20 Thick film 
TME3PAP 5 700 20 Thick film 
* 500 mg of METHO E3P was taken for film formation in further studies. 
4.3.1.1Optimization of Amount of Plasticizer (PEG 400/ Glycerol) for METHO E3P 
4.3.1.2 Optimization of amount of PEG 400 alone as plasticizer for METHO E3P 
Table 13: Optimization of amount of PEG 400 alone as plasticizer for METHO E3P 
Formulation Code 
Amount of METHO 
E3P (mg) 
Amount of 
PEG 400 (mg) 
Amount of 
water (ml) 
Result 
TME3PAPEG 1 500 25 20 Brittle film 
TME3PAPEG 2 500 50 20 Brittle film 
TME3PAPEG 3 500 75 20 Less flexible film 
TME3PAPEG 4 500 100 20 Flexible film 
TME3PAPEG 5 500 125 20 Flexible film 
TME3PAPEG 6 500 150 20 Flexible film but sticky 
* 100 mg of PEG400 alone was taken as plasticizer for METHO E3P in further studies. 
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4.3.2 Optimization of amount of Glycerol alone as plasticizer for METHO E3P 
Table 14: Optimization of amount of Glycerol alone as plasticizer for METHO E3P 
Formulation Code 
Amount of METHO 
E3P (mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TME3PAGL 1 500 25 20 Brittle film 
TME3PAGL 2 500 50 20 Film is not flexible 
TME3PAGL 3 500 75 20 Less flexible film 
TME3PAGL 4 500 100 20 Flexible film 
TME3PAGL 5 500 150 20 Flexible film 
TME3PAGL6 500 200 20 Flexible but sticky film 
*100 mg of Glycerol alone was taken as plasticizer for METHO E3P in further studies. 
4.3.3 Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO E3P 
Table 15: Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO E3P 
Formulation Code 
Amount of 
METHO E3P 
(mg) 
Amount of 
PEG 400 
(mg) 
Amount of 
Glycerol (mg) 
Amount of 
water (ml) 
Result 
TME3PAPGL 1 500 25 25 20 Less flexible film 
TME3PAPGL 2 500 25 50 20 Less flexible film 
TME3PAPGL 3 500 25 75 20 Flexible film 
TME3PAPGL 4 500 50 25 20 Less flexible film 
TME3PAPGL 5 500 50 50 20 Flexible film 
TME3PAPGL6 500 50 75 20 sticky film 
TME3PAPGL 7 500 75 25 20 Less flexible film 
TME3PAPGL8 500 75 50 20 Sticky film 
* Two combinations (a) 25 mg of PEG400 + 75 mg of Glycerol and (b) 50 mg of PEG400 + 50mg of Glycerol were taken as 
plasticizer for METHO E3P in further studies. 
4.3.4 Formulation of rapid dissolving film using METHO E3P as polymer 
Based upon various trial batches, total eight formulations (ME3P01 – ME3P08) were designed for preparation of rapid 
dissolving film using METHO E3P as film former.  
Table 16: Formulation of rapid dissolving film using METHO E3P as polymer 
                   Formulation 
Ingredients 
ME3P01 ME3P02 ME3P03 ME3P04 ME3P05 ME3P06 ME3P07 ME3P08 
METHO E3P (mg) 600 600 600 600 600 600 600 600 
GSH (mg) 27 27 27 27 27 27 27 27 
PEG 400 (mg) 100 100 - - 50 50 25 25 
Glycerol (mg) - - 100 100 50 50 75 75 
Aspartame (mg) 25 - 25 - 15 15 15 15 
Sucralose (mg) - 25 - 25 10 15 10 15 
Citric acid (mg) - 25 20 25 25 30 25 25 
Passion fruit (ml) - 0.1 - 0.1 - 0.1 0.1 - 
Lemon flavor (ml) - - 0.1 - 0.1 - - 0.1 
Distilled Water (ml) 20 20 20 20 20 20 20 20 
In-vitro DT (sec.) 35 37 36 40 34 35 37 36 
In-vivo DT (sec.) 37 33 40 40 35 32 35 37 
Taste 4 2 3 2 3 2 3 3 
* Based upon parameters like disintegration time, taste etc, two formulations i.e., ME3P02 and ME3P06 were found to be 
optimum for preparation of rapid dissolving film using METHO E3P as film former. So, these two films were further studied for 
various parameters. 
4.4 Formulation of rapid dissolving film using Methocel E15 Premium Hydroxyl Propyl Methylcellulose (METHO E15P) 
as film former 
4.4.1 Optimization of Amount of Polymer (METHO E15P) 
Table 17: Optimization of Amount of Polymer - METHO E15P 
Formulation Code 
Amount of METHO 
E15P (mg) 
Amount of 
water (ml) 
Result 
TME15PAP 1 300 20 Very thin film 
TME15PAP 2 400 20 Film formed 
TME15PAP 3 500 20 Film formed 
TME15PAP 4 600 20 Thick film 
TME15PAP 5 700 20 Thick film 
* 400 mg of METHO E15P was taken for film formation in further studies. 
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4.4.2 Optimization of Amount of Plasticizer (PEG 400/ Glycerol) for METHO E15P 
4.4.2.1 Optimization of amount of PEG 400 alone as plasticizer for METHO E15P 
Table 18: Optimization of amount of PEG 400 alone as plasticizer for METHO E15P 
Formulation Code 
Amount of METHO E15P 
(mg) 
Amount of PEG 
400 (mg) 
Amount of water 
(ml) 
Result 
TME15PAPEG 1 400 10 20 Brittle film 
TME15PAPEG 2 400 25 20 Brittle film 
TME15PAPEG 3 400 50 20 Flexible film 
TME15PAPEG 4 400 75 20 Flexible film 
TME15PAPEG 5 400 100 20 Flexible film but sticky 
TME15PAPEG 6 400 125 20 Flexible film but sticky 
 * 50 mg of PEG400 alone was taken as plasticizer for METHO E15P in further studies. 
4.4.3 Optimization of amount of Glycerol alone as plasticizer for METHO E15P 
Table 19: Optimization of amount of Glycerol alone as plasticizer for METHO E15P 
Formulation Code Amount of METHO E15P 
(mg) 
Amount of 
Glycerol (mg) 
Amount of water 
(ml) 
Result 
TME15PAGL 1 400 10 20 Brittle film 
TME15PAGL 2 400 25 20 Film is not flexible 
TME15PAGL 3 400 50 20 Less flexible film 
TME15PAGL 4 400 75 20 Flexible film 
TME15PAGL 5 400 100 20 Flexible film 
TME15PAGL 6 400 150 20 Flexible film but brittle 
 * 75 mg of Glycerol alone was taken as plasticizer for METHO E15P in further studies. 
4.4.4 Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO E15P 
Table 20: Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for METHO E15P 
Formulation Code 
Amount of METHO 
E15P (mg) 
Amount of 
PEG 400 
(mg) 
Amount of 
Glycerol 
(mg) 
Amount of 
water 
(ml) 
Result 
TME15PAPGL 1 400 20 30 20 Less flexible film 
TME15PAPGL 2 400 20 40 20 Less flexible film 
TME15PAPGL 3 400 20 50 20 Flexible film 
TME15PAPGL 4 400 30 30 20 Flexible film 
TME15PAPGL 5 400 30 40 20 Flexible film 
TME15PAPGL6 400 30 50 20 sticky film 
TME15PAPGL 7 400 40 30 20 Less flexible film 
TME15PAPGL8 400 40 40 20 Sticky film 
* Two combinations (a) 20 mg of PEG400 + 50 mg of Glycerol and (b) 30 mg of PEG400 + 30mg of Glycerol were taken as 
plasticizer for METHO E15P in further studies. 
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4.4.5 Formulation of rapid dissolving film using METHO E15P as polymer 
Based upon various trial batches, total eight formulations (ME15P01 – ME15P08) were designed for preparation of rapid 
dissolving film using METHO E15P as film former.  
Table 21: Formulation of rapid dissolving film using METHO E15P as polymer 
                Formulation 
Ingredients 
ME15P01 ME15P02 ME15P03 ME15P04 ME15P05 ME15P06 ME15P07 ME15P08 
METHO E15P (mg) 400 400 400 400 400 400 400 400 
GSH (mg) 27 27 27 27 27 27 27 27 
PEG 400 (mg) 50 50 - - 20 20 30 30 
Glycerol (mg) - - 75 75 50 50 30 30 
Aspartame (mg) 20 - 20 - 10 10 15 15 
Sucralose (mg) - 20 - 20 10 10 05 05 
Citric acid (mg) - 20 15 20 20 25 20 25 
Passion fruit (ml) - 0.1 - 0.1 - 0.1 - 0.1 
Lemon flavor (ml) - - 0.1 - 0.1 - 0.1 - 
Distilled Water (ml) 20 20 20 20 20 20 20 20 
In-vitro DT (sec.) 34 35 37 39 40 39 38 36 
In-vivo DT (sec.) 35 37 42 41 43 41 34 38 
Taste 4 2 3 2 3 3 3 2 
* Based upon parameters like disintegration time, taste etc, two formulations i.e., ME5P02 and ME5P08 were found to be 
optimum for preparation of rapid dissolving film using METHO E15P as film former. So, these two films were further studied for 
various parameters. 
4.4.6 Formulation of rapid dissolving film using POLYOX WSR N10 (POLY N10) as film former 
4.4.6.1 Optimization of Amount of Polymer (POLY N10) 
Table 22: Optimization of Amount of Polymer - POLY N10 
Formulation 
Code 
Amount of 
POLY N10 (mg) 
Amount of 
water (ml) 
Result 
TPN10AP 1 300 20 No film 
TPN10AP 2 400 20 Very thin film 
TPN10AP 3 500 20 Film formed 
TPN10AP 4 600 20 Thick film 
TPN10AP 5 700 20 Thick film 
* 500 mg of POLY N10 was taken for film formation in further studies. 
4.4.6.2 Optimization of Amount of Plasticizer (PEG 400/ Glycerol) for POLY N10 
4.4.6.3 Optimization of amount of PEG 400 alone as plasticizer for POLY N10 
Table 23: Optimization of amount of PEG 400 alone as plasticizer for POLY N10 
Formulation Code 
Amount of POLY 
N10 (mg) 
Amount of 
PEG 400 (mg) 
Amount of water  
(ml) 
Result 
TPN10APEG 1 500 25 20 Brittle film 
TPN10APEG 2 500 50 20 Less Flexible film 
TPN10APEG 3 500 75 20 Flexible film 
TPN10APEG 4 500 100 20 Flexible film 
TPN10APEG 5 500 150 20 Flexible film but sticky 
* 75 mg of PEG400 alone was taken as plasticizer for POLY N10 in further studies. 
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4.4.6.3 Optimization of amount of Glycerol alone as plasticizer for POLY N10 
Table 24: Optimization of amount of Glycerol alone as plasticizer for POLY N10 
Formulation Code 
Amount of 
POLY N10 (mg) 
Amount of 
Glycerol (mg) 
Amount of 
water  (ml) 
Result 
TPN10AGL 1 500 25 20 Brittle film 
TPN10AGL 2 500 50 20 Film is not flexible 
TPN10AGL 3 500 75 20 Less flexible film 
TPN10AGL 4 500 100 20 Flexible film 
TPN10AGL 5 500 150 20 Flexible film 
TPN10AGL6 500 200 20 Flexible but sticky film 
* 100 mg of Glycerol alone was taken as plasticizer for POLY N10 in further studies. 
4.4.6.4 Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for POLY N10 
Table 25: Optimization of amount of combination of PEG 400 and Glycerol as plasticizer for POLY N10 
Formulation Code 
Amount of 
POLY N10 
(mg) 
Amount of 
PEG 400 
(mg) 
Amount of 
Glycerol 
(mg) 
Amount of 
water  
(ml) 
Result 
TPN10APGL 1 500 25 25 20 Less flexible film 
TPN10APGL 2 500 25 50 20 Flexible film 
TPN10APGL 3 500 25 75 20 Flexible film 
TPN10APGL 4 500 50 25 20 Flexible film 
TPN10APGL5 500 50 50 20 Flexible film 
TPN10APGL6 500 50 75 20 Sticky film 
* Two combinations (a) 25 mg of PEG400 + 50 mg of Glycerol and (b) 50 mg of PEG400 + 25mg of Glycerol were taken as 
plasticizer for POLY N10 in further studies. 
4.4.7 Formulation of rapid dissolving film using POLY N10 as polymer 
Based upon various trial batches, total eight formulations (PN01 – PN08) were designed for preparation of rapid dissolving film 
using POLY N10 as film former.  
Table 26: Formulation of rapid dissolving film using POLY N10 as polymer 
                      Formulation 
Ingredients 
PN01 PN02 PN03 PN04 PN05 PN06 PN07 PN08 
POLY N10 (mg) 500 500 500 500 500 500 500 500 
GSH (mg) 27 27 27 27 27 27 27 27 
PEG 400 (mg) 75 75 - - 25 25 50 50 
Glycerol (mg) - - 100 100 50 50 25 25 
Aspartame (mg) 25 - 25 - 15 15 15 15 
Sucralose (mg) - 25 - 25 10 15 10 15 
Citric acid (mg) - - 20 25 25 30 25 25 
Passion fruit (ml) - 0.1 - 0.1 - 0.1 - 0.1 
Lemon flavor (ml) - - 0.1 - 0.1 - 0.1 - 
Distilled Water (ml) 20 20 20 20 20 20 20 20 
In-vitro DT (sec.) 25 26 28 27 20 30 23 22 
In-vivo DT (sec.) 27 25 30 29 25 28 25 24 
Taste 4 3 3 3 2 2 3 2 
* Based upon parameters like disintegration time, taste etc, two formulations i.e., PN05 and PN08 were found to be optimum for 
preparation of rapid dissolving film using POLY N10 as film former. So, these two films were further studied for various 
parameters. 
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4.5 FINAL FORMULA FOR FORMULATION OF RAPID DISSOLVING FILM USING VARIOUS POLYMERS AS FILM FORMER 
Based upon above studies, following ten formulations were finalized as optimum for preparation of rapid dissolving film. These 
ten formulations were further studied for various parameters. 
Table 27: Formulation of rapid dissolving film using various polymers as film former 
Formulation Code FF01 FF02 FF03 FF04 FF05 FF06 FF07 FF08 FF09 FF10 
             Formulation 
Ingredients 
P03 P06 MK3P04 MK3P06 ME3P02 ME3P06 ME15P02 ME15P08 PN05 PN08 
PULLULAN (mg) 500 500 - - - - - - - - 
METHO K3P (mg) - - 600 600 - - - - - - 
METHO E3P (mg) - - - - 600 600 - - - - 
METHO E15P (mg) - - - - - - 400 400 - - 
POLY N10 (mg) - - - - - - - - 500 500 
GSH (mg) 27 27 27 27 27 27 27 27 27 27 
PEG 400 (mg) - 50 - 50 100 50 50 30 25 50 
Glycerol (mg) 100 75 75 50 - 50 - 30 50 25 
Aspartame (mg) 25 15 - 15 - 15 - 15 15 15 
Sucralose (mg) - 15 25 15 25 15 20 05 10 15 
Citric acid (mg) 20 30 25 30 25 30 20 25 25 25 
Passion fruit (ml) 0.1 0.1 - - 0.1 0.1 0.1 0.1 - 0.1 
Lemon flavor (ml) - - 0.1 0.1 - - - - 0.1 - 
Distilled Water (ml) 20 20 20 20 20 20 20 20 20 20 
In-vitro DT (second) 40 45 35 28 37 35 35 36 20 22 
In-vivo DT (second) 35 39 30 34 33 32 37 38 25 24 
Taste 2 2 2 2 2 2 2 2 2 2 
 
4.6 FINAL FORMULA FOR FORMULATION OF RAPID DISSOLVING FILM OF ONDANSETRON HYDROCHLORIDE 
Based upon various evaluation parameters of RDF of Granisetron hydrochloride, using various polymers and other excipients, 
two formulations were found to be optimum i.e. FF2 and FF8. So, combination of these polymers and other excipients were 
used to prepare RDF of Ondansetron hydrochloride (OFF1 and OFF2). 
Table 28: Formulation of rapid dissolving film of Ondansetron hydrochloride 
                          Formulation 
Ingredients 
OFF1 OFF2 
PULLULAN (mg) 500 - 
METHO E15P (mg) - 400 
OND (mg) 60 60 
PEG 400 (mg) 50 30 
Glycerol (mg) 75 30 
Aspartame (mg) 15 15 
Sucralose (mg) 15 05 
Citric acid (mg) 30 25 
Passion fruit (ml) 0.1 0.1 
Distilled Water (ml) 20 20 
In-vitro DT (second) 47 38 
In-vivo DT (second) 42 37 
Taste 2 2 
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5. CONCLUSION: 
In the present work, mouth dissolving films containing 
Granisetron hydrochloride and Ondansetron hydrochloride 
were developed to dissolve immediately in mouth for fast 
drug action. The work included the development, 
characterization and evaluation of rapid dissolving films for 
dissolution in mouth and release the drug for rapid onset of 
action. Granisetron hydrochloride and Ondansetron 
hydrochloride were selected as model drugs for the study. 
Both the drugs are antiemetic. In emesis, quick drug action is 
required and intake of water is also not acceptable. So, rapid 
dissolving film of these two drugs were developed and 
evaluated. Rapid dissolving films of both the drugs 
Granisetron hydrochloride and Ondansetron hydrochloride 
were prepared using various polymers and other excipients 
that dissolve rapidly and release the drugs for rapid 
absorption.Solvent evaporation method was used for 
preparation of the film. Various polymers used in the study 
were: Pullulan, Metho K3P, Metho E3P, Metho E15P and Poly 
N10. PEG-400 and glycerol were used as plasticizer. 
Aspartame and sucralose were used as sweetening agent 
while citric acid was used as saliva stimulating agent. 
Passion fruit and lemon flavour were used as flavouring 
agent. 
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